Dr. Mezzanotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2660 W Chester Pike
Broomall, PA 19008Phone+1 610-527-4980
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1992
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1984 - 1988
- Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
- PA State Medical License 1985 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 87 citationsEosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.Peter M.A. Calverley, Kay Tetzlaff, Claus Vogelmeier, Leonardo M. Fabbri, Helgo Magnussen
American Journal of Respiratory and Critical Care Medicine. 2017-11-01 - 137 citationsDesign of the PF-ILD trial: A double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R. Flaherty, Kevin K. Brown, Athol U. Wells, Emmanuelle Clerisme-Beaty, Harold R. Collard
BMJ Open Respiratory Research. 2017-09-01 - 25 citationsEfficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: Randomized controlled trial comparing once- and twice-daily dosing in patients with asthmaWilliam E. Berger, Eugene R Bleecker, L. O'Dowd, Christopher J. Miller, William S. Mezzanotte
Allergy and Asthma Proceedings. 2010-01-01
Press Mentions
- BELLUS Health Appoints William Mezzanotte, MD, MPH to Its Board of DirectorsMarch 24th, 2021
- For Maintenance Treatment of Asthma in ChildrenFebruary 16th, 2017
- Boehringer Ingelheim Welcomes Central Role of LAMA/LABA Therapy Within 2017 GOLD Strategy for COPDNovember 16th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: